When a clinical trial turns into a win-win game
Her-2 dual blockade strategy in the curative treatment of early breast cancer
2 COMENTÁRIOS
Her-2 dual blockade strategy in the curative treatment of early breast cancer
2 COMENTÁRIOS
Adjuvant TKI and neoadjuvant immunotherapy blow favorable winds
4 COMENTÁRIOS
Should supplementation be considered?
4 COMENTÁRIOS
Benefits associated with personalized medicine
1 COMENTÁRIOS